Adaptive Biotechnologies Corporation
ADPT
$24.77
$0.431.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 71.55M | 70.87M | 71.68M | 93.97M | 58.88M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 71.55M | 70.87M | 71.68M | 93.97M | 58.88M |
| Cost of Revenue | 39.32M | 42.33M | 39.99M | 41.83M | 42.13M |
| Gross Profit | 32.24M | 28.54M | 31.69M | 52.15M | 16.75M |
| SG&A Expenses | 47.58M | 47.33M | 44.04M | 41.43M | 41.36M |
| Depreciation & Amortization | 423.00K | 419.00K | 429.00K | 428.00K | 423.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 87.32M | 90.08M | 84.45M | 83.68M | 83.92M |
| Operating Income | -15.77M | -19.21M | -12.77M | 10.29M | -25.04M |
| Income Before Tax | -39.94M | -20.02M | -13.58M | 9.55M | -25.59M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -39.94M | -20.02M | -13.58M | 9.55M | -25.59M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 153.00K | -18.00K | 0.00 | 1.00K | -21.00K |
| Net Income | -39.79M | -20.03M | -13.58M | 9.55M | -25.61M |
| EBIT | -15.77M | -19.21M | -12.77M | 10.29M | -25.04M |
| EBITDA | -12.08M | -15.37M | -8.58M | 14.70M | -20.53M |
| EPS Basic | -0.25 | -0.13 | -0.09 | 0.06 | -0.17 |
| Normalized Basic EPS | -0.06 | -0.08 | -0.06 | 0.04 | -0.11 |
| EPS Diluted | -0.25 | -0.13 | -0.09 | 0.06 | -0.17 |
| Normalized Diluted EPS | -0.06 | -0.08 | -0.06 | 0.04 | -0.11 |
| Average Basic Shares Outstanding | 159.86M | 155.52M | 153.13M | 152.43M | 152.08M |
| Average Diluted Shares Outstanding | 159.86M | 155.52M | 153.13M | 163.16M | 152.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |